385 related articles for article (PubMed ID: 10469018)
1. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
[TBL] [Abstract][Full Text] [Related]
2. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
Pfeifer M; Kanc K; Verhovec R; Kocijancic A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
[TBL] [Abstract][Full Text] [Related]
4. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
[TBL] [Abstract][Full Text] [Related]
6. Anterior pituitary dysfunction in survivors of traumatic brain injury.
Agha A; Rogers B; Sherlock M; O'Kelly P; Tormey W; Phillips J; Thompson CJ
J Clin Endocrinol Metab; 2004 Oct; 89(10):4929-36. PubMed ID: 15472187
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.
Tuchelt H; Dekker K; Bähr V; Oelkers W
Clin Endocrinol (Oxf); 2000 Sep; 53(3):301-7. PubMed ID: 10971446
[TBL] [Abstract][Full Text] [Related]
8. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
10. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
[TBL] [Abstract][Full Text] [Related]
12. Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.
Arvat E; Maccagno B; Ramunni J; Giordano R; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Nov; 143(5):601-6. PubMed ID: 11078983
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.
Gianotti L; Ramunni J; Lanfranco F; Maccagno B; Giordano R; Broglio F; Maccario M; Muller EE; Ghigo E; Arvat E
J Endocrinol Invest; 2001 Feb; 24(2):67-71. PubMed ID: 11263473
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
[TBL] [Abstract][Full Text] [Related]
17. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
[TBL] [Abstract][Full Text] [Related]
18. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.
Giordano R; Grottoli S; Brossa P; Pellegrino M; Destefanis S; Lanfranco F; Gianotti L; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2003 Sep; 59(3):314-20. PubMed ID: 12919154
[TBL] [Abstract][Full Text] [Related]
19. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome.
Moorkens G; Berwaerts J; Wynants H; Abs R
Clin Endocrinol (Oxf); 2000 Jul; 53(1):99-106. PubMed ID: 10931086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
